US EditionPopular injected weight loss medications work better for one sex. Researchers want to know why
- Researchers observed that Wegovy, an injected weight loss medication, produces varying rates of weight loss in clinical trial participants over several months.
- This variability occurs as Wegovy reaches peak concentration within one to three days and works alongside healthy lifestyle changes participants made throughout the trials.
- Over an eight-week period, participants reduced their body weight by about four percent on average, and with continued adherence to lifestyle changes like strength training and adequate protein consumption, some achieved up to a 20 percent weight loss after 68 weeks.
- Dr. Craig Primack, who holds a leadership role in weight management at Hims & Hers, suggests a daily intake of 100 grams of protein combined with strength training to promote healthy weight loss and maintain muscle mass.
- These findings suggest Wegovy combined with lifestyle changes may lead to steady, sustained weight loss, but individual responses and timelines can vary widely.
8 Articles
8 Articles
How Long Does It Take for Wegovy To Work?
This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. When considering a weight loss medication — or any medication — it’s normal to wonder when the effects will kick in. So, how long does it take for Wegovy to work? The Wegovy weight loss timeline can vary a bit between individuals, but Wegovy goes to work pretty quickly, with the medication reaching peak concentration in your body within one to three days. In clinical trials, pe…
Popular Medications for Breastfeeding Have More Effect in One of the Sexes
You have probably already heard these stories: for every man who cuts carbohydrates from the diet and loses 5 pounds, there is a woman who does exactly the same and loses only 1. Research confirms this frustrating data — diet and exercise are used to bring far better results for men than for women when the subject is weight loss. Therefore, the results of recent clinical trials have been surprising — and they have encouraged — many people: in th…
Coverage Details
Bias Distribution
- 83% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
